Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 13;9(6):00138-2023.
doi: 10.1183/23120541.00138-2023. eCollection 2023 Nov.

Compartment-specific protein interactions in beryllium lung disease

Affiliations

Compartment-specific protein interactions in beryllium lung disease

Li Li et al. ERJ Open Res. .

Abstract

The study provides insights into proteins that may be relevant in BeS and CBD. It provides a framework to investigate the global changes in lung compartment-specific inflammatory cells to better understand the potential interplay of proteins in CBD. https://bit.ly/3PLNTXC.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: L. Li received support for the present manuscript from NIH HHS/USA grants R01ES023826, R01ES033678, R01ES025722, R01ES034767 and K01ES020857. Conflict of interest: I.V. Yang received support for the present manuscript from NIH HHS/USA grants R01ES023826, R01ES033678 and R01ES025722; consulting fees were received from Eleven P15, outside the submitted work; and she is an unpaid Chair for the American Thoracic Society Section on Genetics and Genomics, outside the submitted work. Conflict of interest: L.A. Maier received support for the present manuscript from NIH HHS/USA grants R01ES023826, R01ES033678 and R01ES025722. Conflict of interest: M. Bhargava received support for the present manuscript from NIH HHS/USA grant R01ES025722; and grants or contracts from R01HL153613 (Comprehensive Proteomic Classifier for the Molecular Characterization of Pulmonary Sarcoidosis; PI M. Bhargava, MPI Maier), KIN-1902-2001 (A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open Label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis; Site PI M. Bhargava); FSR Pilot Grant (Comprehensive Assessment Of Signal Transduction Pathways in Sarcoidosis; PI M. Bhargava) ATYR1923-C-004 (A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients with Pulmonary Sarcoidosis; Site PI M. Bhargava), Chest Foundation (Inflammatory Protein Panel for Sarcoidosis Diagnosis and Prognosis; PI M. Bhargava), outside the submitted work; and has patents planned, issued or pending (Ingbar D, Rich T, Schumacher R, et al. (2022). Composition and Methods for Treating Pulmonary Edema or Lung Inflammation. American Inventors), outside the submitted work. Conflict of interest: The remaining authors have nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Protein pathways and modules linked to beryllium sensitisation (BeS) and chronic beryllium disease (CBD). Quantile normalised and log transformed protein abundances were analysed for identifying differentially abundant proteins (DAPs) in the three comparison groups as well as protein modules that were different in the three groups using Weighted Gene Co-expression Network Analysis in R. a) Overview of the proteins with differential abundance (DA) (p<0.05). b) Heatmap of proteins that demonstrated a significant monotonic increase or decrease in their abundance going from controls to BeS to CBD. c) “Overlapping analysis” in Ingenuity Pathway Analysis (IPA) for canonical pathways mapping to DAPs in BeS and CBD comparison. The edges (i.e., the lines drawn between two related pathways/nodes) represent the relationship of these pathways and are shown only between any pair of pathways that have at least four shared proteins. Moreover, the thickness of the edges is proportional to the total number of shared proteins in the connected pathways with thicker lines indicative of a larger number. Highly connected pathways such sirtuin and oestrogen receptor signalling may be critical in BeS and CBD pathogenesis. d) The results of Weighted Gene Co-expression Network Analysis (WGCNA) where 14 distinct modules were identified. Several modules identified by WGCNA demonstrate DA in BeS or CBD compared to controls and BeS compared with CBD. False discovery rate (FDR) adjusted p-values for each pairwise comparison of module eigen-protein loadings as obtained using t-tests on regression coefficients from linear mixed models. Those with an FDR <0.05 are highlighted in red.

References

    1. Newman LS, Mroz MM, Balkissoon R, et al. . Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 2005; 171: 54–60. doi:10.1164/rccm.200402-190OC - DOI - PubMed
    1. Bhargava M, Viken KJ, Barkes B, et al. . Novel protein pathways in development and progression of pulmonary sarcoidosis. Sci Rep 2020; 10: 13282. doi:10.1038/s41598-020-69281-8 - DOI - PMC - PubMed
    1. Benjamini Y. Discovering the false discovery rate. J R Stat Soc B 2010; 72: 405–416. doi:10.1111/j.1467-9868.2010.00746.x - DOI
    1. Cox J, Hein MY, Luber CA, et al. . Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed maxlfq. Mol Cell Proteomics 2014; 13: 2513–2526. doi:10.1074/mcp.M113.031591 - DOI - PMC - PubMed
    1. Elangovan S, Ramachandran S, Venkatesan N, et al. . SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor alpha in breast cancer. Cancer Res 2011; 71: 6654–6664. doi:10.1158/0008-5472.CAN-11-1446 - DOI - PMC - PubMed

LinkOut - more resources